Emergent BioSolutions Inc. (EBS)
NYSE: EBS · IEX Real-Time Price · USD
2.530
-0.060 (-2.32%)
At close: Mar 28, 2024, 4:00 PM
2.590
+0.060 (2.37%)
After-hours: Mar 28, 2024, 7:37 PM EDT

Emergent BioSolutions Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2003
Net Income
-760.5-211.6219.5305.854.562.782.651.862.8736.74
Upgrade
Depreciation & Amortization
125.1143.3123.8114.5110.762.242.638.235.3432.45
Upgrade
Share-Based Compensation
23.145.142.451.826.723.215.27.94.576.84
Upgrade
Other Operating Activities
406-10.9-65.564.8-3.9-106.367.7-43.3-60.2636.28
Upgrade
Operating Cash Flow
-206.3-34.1320.2536.918841.8208.154.642.52112.32
Upgrade
Operating Cash Flow Growth
---40.36%185.59%349.76%-79.91%281.14%28.42%-62.15%15.83%
Upgrade
Capital Expenditures
-51.6-115.8-224.1-141.9-86.9-72.1-54.8-76.2-44.81-30.67
Upgrade
Acquisitions
263.9-243.70-10-10-827.7-195.10-0.65-179.38
Upgrade
Other Investing Activities
--21.8---2.6----
Upgrade
Investing Cash Flow
212.3-381.3-224.1-151.9-96.9-897.2-249.9-76.2-45.46-210.05
Upgrade
Share Issuance / Repurchase
10.2-77.1-90.131.68.215.8-13.817.125.8613.88
Upgrade
Debt Issued / Paid
-543.4564.2-35.954.513.7781.8-21.402180.59
Upgrade
Other Financing Activities
-2.5-5.9-15-16.6-57.8-8.9-16.2-36.97.534.41
Upgrade
Financing Cash Flow
-535.7481.2-14169.5-35.9788.7-51.4-19.835.39198.87
Upgrade
Exchange Rate Effect
-1.20.5-0.3-10.4-0.200.1-0.150.02
Upgrade
Net Cash Flow
-530.966.3-45.2453.555.6-66.9-93.2-41.332.3101.16
Upgrade
Free Cash Flow
-257.9-149.996.1395101.1-30.3153.3-21.6-2.381.65
Upgrade
Free Cash Flow Growth
---75.67%290.70%-----48.59%
Upgrade
Free Cash Flow Margin
-24.58%-13.41%5.42%25.04%9.14%-3.87%27.33%-4.42%-0.47%20.19%
Upgrade
Free Cash Flow Per Share
-5.04-2.991.807.501.96-0.603.67-0.54-0.062.19
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).